Ennis & Ennis, P.A. Supports Petition To Remove Ortho Evra Birth Control Patch From U.S. Market
-Open Press
05/12/2008- Ennis & Ennis, P.A. is supporting the petition to the FDA, filed by Public Citizen, to remove the Ortho Evra Birth Control Patch from the U.S. market. More>>>
Birth Control Patch – A Threat for Women, FDA Pressed to Remove It
-eNews 2.0
05/12/2008- The Ortho-Evra birth control patch is far riskier than the pill, a consumer advocacy group said. The group petitioned the government to remove the birth control patch from the market, as it represents a threat for women who use it. More>>>
Ortho Evra Needs to Go, Public Citizen Says
-NEWSInferno.com
05/10/2008- A prominent consumer advocacy group says Ortho Evra, Johnson & Johnson’s controversial birth control patch, is too dangerous to be on the market. Public Citizen is asking federal regulators to ban Ortho Evra because it poses a higher risk of potentially fatal blood clots than other hormone-based contraceptives. More>>>
Ortho Evra: Convenience at a Terrible Cost
-Lawyers and Settlements
05/09/2008- She was just 18 when the Ortho Evra patch claimed her life. A student, studying for a career in fashion. After she collapsed in a Manhattan subway in April 2005 and subsequently died, an autopsy revealed that a blood clot had formed and moved into the young lady's lung. More>>>
US group wants FDA to pull J&J birth control patch
-Reuters
05/08/2008- A U.S. advocacy group is urging the Food and Drug Administration to pull Johnson & Johnson's birth control patch from the market after studies found an increased risk of dangerous blood clots. More>>>
Ortho Evra Patch: Silence Is Not the Answer
-Lawyers and Settlements
05/07/2008- Currently, more than 3,000 women and their families in the United States are suing Johnson and Johnson, the makers of the Ortho Evra birth control patch, because they have suffered life threatening adverse health effects such as blood clots, heart attacks, and stroke, as a result of using this controversial form of birth control. Some 40 women have died while using it. More>>>
1st suspected victim of Ortho Evra reported in Taiwan
-The China Post
04/29/2008 - The controversial Ortho Evra birth control patch, marketed in Taiwan as the Evra Transdermal Patch, may have claimed its first victim on the island. More>>>
Ortho Evra Patch Makers Settling Cases
-PRNewswire
04/22/2008 - Evidence shows that Ortho Evra is dangerous and should be recalled from the market. Studies found that women using the Ortho Evra birth control patch were twice as likely to develop blood clots compared with those using oral birth control pills. More>>>
Consumer watch — Johnson & Johnson and the FDA
-SeacoastOnline
04/17/2008 - What's worse than breast tenderness and nausea in the female effort to prevent pregnancy? Heart attack, stroke or death. Quitting this week is going to consider the everyday erosions of our medical liberties by the political and economic culture at large. More>>>
Relying 'Solely' On FDA To Judge Safety Of Ortho Evra Patch Is A Mistake, Editorial Says
- Medical NewsToday
04/16/2008 - It would be a mistake to "rely solely" on FDA to judge the safety and efficacy of the birth control patch Ortho Evra, a New York Times editorial says.More>>>
Bush's Attempts to Undermine Tort Claims Criticized
-RegWatch
04/15/2008 - An editorial in today's New York Times condemns a policy, known as preemption, which prohibits consumers from suing manufacturers if a product harms a consumer, so long as that product is in some way regulated by the federal government. More>>>
The Dangers in Pre-emption
-New York Times
04/14/2008- The pharmaceutical industry and its good friends in the Bush administration are working hard to prevent consumers from filing damage suits for injuries caused by federally approved drug products. They may soon get a helping hand from the Supreme Court, which has already barred many suits over faulty medical devices. More>>>
Johnson & Johnson seeks to put blame on regulators
-HeraldTribune
04/12/2008-For years, Johnson & Johnson obscured evidence that its popular Ortho Evra birth control patch delivered much more estrogen than standard birth control pills, potentially increasing the risk of blood clots and strokes, according to internal company documents. More>>>
A prescription for drug disaster
- Georgetown Voice
04/11/2008 - If an Ohio District Court rules in favor of Johnson & Johnson in an upcoming case, it will set the precedent that drug companies are no longer responsible for their medicines’ unadvertised side effects. This legal shield would let drug companies literally get away with murder. More>>>
Big Pharma & A Killer Ruling Expected From George Bush’s Activist Supreme Court
- The Moderate Voice
04/10/2008 - There is an old saying that Americans have to live with the decisions of the Supreme Court for the rest of their lives and then some, but that takes on a perverse new meaning for those who are maimed or their lives cut short by shoddily researched and falsely advertised medications that are inadequately vetted by the Food and Drug Administration and let slide by President Bush’s activist Supreme Court. More>>>
New York Times Examines Johnson And Johnson's Pre-Emption Defense Over Safety Of Birth Control Patch
- Medical News Today
04/09/2008 - The New York Times on Sunday examined Johnson & Johnson's use of the legal doctrine of preemption to defend against claims that the birth control patch Ortho Evra causes blood clots or other adverse effects. More>>>
A dangerous legal shield for drug makers
- News Tribune
04/08/2008 - Let’s say a drug company hides damaging findings during medical trials of a new cholesterol-lowering drug. Unaware of those health risks, the federal Food and Drug Administration approves the product. More>>>
If J&J misled FDA, can patients sue?
- Fierce Pharma
04/08/2008 - Drug companies appear to be close to gaining a long-coveted prize: A shield against patient lawsuits. The Bush administration has been arguing in favor of it, saying that only the FDA has the expertise to regulate pharma. More>>>
Odds Rise for FDA Shield Against Drug Liability
-Wall Street Journal
04/07/2008 - Johnson & Johnson maintains that it can’t be sued by thousands of women who claim they were injured by the company’s birth control patch because the FDA approved the product as safe and effective. More>>>
Drug Makers Near Old Goal: A Legal Shield
- NY Times
04/07/2008 - For years, Johnson & Johnson obscured evidence that its popular Ortho Evra birth control patch delivered much more estrogen than standard birth control pills, potentially increasing the risk of blood clots and strokes, according to internal company documents. More>>>
J&J Hid Safety Risk Data on Birth-Control Device, Women Claim
-Bloomberg
04/05/2008- Johnson & Johnson hid or altered data on the health risks of its Ortho Evra birth-control patch and flaws in the manufacturing of the device, lawyers for women suing the company claim in court papers. More>>>
Birth Control Patch Under Fire
- NBC News
03/24/08 - The birth control patch gives millions of women the freedom of not taking a pill every day. But one Bay Area woman believes that convenience caused her a potentially life-threatening condition and now she's part of a class action lawsuit. More>>>
FDA approves update to label on Ortho birth control patch
- Grand Forks Herald
02/01/08 - The U.S. Food and Drug Administration approved additional changes to the Ortho Evra Contraceptive Transdermal (Skin) Patch label to include the results of a new epidemiology study that found that users of the birth control patch were at higher risk of developing serious blood clots, also known as venous thromboembolism or VTE, than women using birth control pills. VTE can lead to pulmonary embolism. More>>>
Health Canada raises red flag on birth control patch
- Brock Press
01/30/08 - The Evra birth control patch may be more convenient than the pill for many Canadian women, but while new evidence suggests it may also be more dangerous, doctors are urging calm. More>>>
Revised Warning for Ortho Evra Patch
-FDA News
01/28/2008 - The warnings section of physician labeling for Johnson & Johnson’s (J&J) birth control patch Ortho Evra was updated Jan. 18 to reflect data from a new epidemiology study that found the product increases the risk of venous thromboembolism (VTE) when compared with traditional birth control pills. VTE can lead to pulmonary embolism, the FDA said. More>>>
FDA Announces Ortho Evra Label Will Include New Data On Increased Risk Of Blood Clots
- Medical News Today
01/24/2008 - FDA on Friday announced that the label for the birth control patch Ortho Evra -- made by Johnson & Johnson subsidiary Ortho McNeil -- will include new data on a study that found a higher risk of blood clots among women who use the patch, Reuters Health reports. More>>>
Review Looks at Latest Birth Control Options
- Health Behavior News Science
01/24/2008 - With many women still searching for the perfect birth control method, a systematic review analyzes a host of studies comparing the contraceptive skin patch or vaginal ring to the pill. Although perfection remains elusive and choices are equally effective, the review authors were able to pinpoint some preferences. More>>>
Blood clot risk found in patch
- CBS news
01/22/2008 - The U.S. Food and Drug Administration has approved additional changes to the Ortho Evra Contraceptive Transdermal (Skin) Patch label. More>>>
FDA Approves Update to Label on Birth Control Patch
- Trading Markets
01/21/2008 - The U.S. Food and Drug Administration (FDA) today approved additional changes to the Ortho Evra Contraceptive Transdermal (Skin) Patch label to include the results of a new epidemiology study that found that users of the birth control patch were at higher risk of developing serious blood clots, also known as venous thromboembolism (VTE), than women using birth control pills. VTE can lead to pulmonary embolism. More>>>
Birth Control Patch Raises Risk Of Venous Thromboembolism, FDA
-Medical News Today
01/18/2008 - A woman who uses the Ortho Evra Contraceptive Transdermal Patch runs a higher risk of developing VTE (venous thromboembolism) - serious blood clots - compared to a woman who does not use the patch, prompting the Food and Drug Administration (FDA) to approve additional changes to the patch's label. The FDA informs that VTE can lead to pulmonary embolism. More>>>
J&J contraceptive patch to include more risk data
-Reuters
01/21/2008 - The label for a Johnson & Johnson contraceptive patch will include new data from a second study showing a higher risk of blood clots compared with birth-control pills, U.S. regulators said on Friday. More>>>
Blood clots, deaths linked to Evra
-The Gazette, Canada
01/11/2008 - The Evra birth control patch may be more convenient than the pill for many Canadian women, but new evidence suggests it may also be more dangerous. More>>>
Drug company, adverse reaction report remind of birth control blood clot risks
-GlobeLife, Canada
01/09/2008 - Sixteen cases of blood clots and one heart attack among users of a birth control patch have been reported since the patch was introduced to Canada in early 2004, says a report. More>>>
Red flag for birth control patch
-GlobeLife, Canada
01/09/2008 - Two Canadian women have died and numerous others have suffered blood clots, heart attacks and other medical problems in the span of about four years after using the well-known but increasingly controversial Evra birth-control patch, according to a Health Canada report. More>>>
If you or someone you love has used the Ortho Evra Birth Control Patch and has experienced side effects such as: heart attack, stroke, blood clots, or deep vein thrombosis (DVT) you need to know your legal rights. Call our Ortho Evra side effects lawyers for a free legal consultation or to ask questions about a possible Ortho Evra lawsuit or Ortho Evra recall.
|